You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

wet macular degeneration

Showing 1 - 25 of 3,798
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

Not yet recruiting
  • Age-related Wet Macular Degeneration
  • CG-P5 peptide
  • +2 more
  • Augusta, Georgia
  • +3 more
Nov 13, 2023

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Neovascular Age-related Macular Degeneration Trial (FT-003)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • FT-003
  • (no location specified)
Nov 21, 2022

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023

Russian Registry of Patients With nAMD

Terminated
  • Neovascular Age-Related Macular Degeneration
  • nAMD
  • (no location specified)
Jan 16, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Austin, Texas
    Retina Consultants of Austin
Jan 16, 2023

Macular Degeneration, Wet, Metamorphopsia Trial

Recruiting
  • Macular Degeneration, Wet
  • Metamorphopsia
    • Cuneo, Piedmont, Italy
      Ospedale Santa Croce
    Sep 20, 2022

    Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • LX102-C01 Injection
    • Shanghai, China
      Shanghai General Hospital, Shanghai Jiao Tong University School
    Apr 14, 2023

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

    Suspended
    • Neovascular Age-related Macular Degeneration
    • Diabetic Macular Edema
    • Intravitreal injection of IBI302(dose 1)
    • +3 more
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jul 17, 2023

    Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • IBI333
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Nov 28, 2022

    Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • AR-14034 SR implant lower dose
    • +3 more
    • (no location specified)
    Mar 3, 2023

    Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration(nAMD)
    • HG202
    • Shanghai, Shanghai, China
    • +1 more
    Sep 4, 2023

    Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • SKG0106
    • Katy, Texas
    • +1 more
    Aug 15, 2023

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

    Withdrawn
    • Wet Macular Degeneration
    • Aflibercept 40 MG/ML [Eylea]
    • +2 more
    • Prague, Czechia
      Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
    Aug 7, 2022

    Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • NG101 AAV gene therapy
    • Toronto, Ontario, Canada
      Vitreous Retina Macula Specialists of Toronto
    Aug 2, 2023

    Neovascular Age-related Macular Degeneration Trial in Seongnam-si (Probiotic Combination Cap/Tab, intravitreal Anti-VEGF

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Probiotic Combination Cap/Tab
    • intravitreal Anti-VEGF injection
    • Seongnam-si, Korea, Republic of
      Seoul National University Bundang Hospital
    Nov 1, 2022